These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1690498)

  • 1. A transient acidification linked to intracellular Ca2+ in anti-mu-stimulated human B-lymphocytes.
    Schøyen H; Iversen JG; Smeland EB; Heikkilä R
    Acta Physiol Scand; 1990 Feb; 138(2):221-7. PubMed ID: 1690498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C; Grillot-Courvalin C; Labaume S; Miglierina R; Brouet JC
    Eur J Immunol; 1988 Nov; 18(11):1811-7. PubMed ID: 3144454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The B lymphocyte calcium response to anti-Ig is diminished by membrane immunoglobulin cross-linkage to the Fc gamma receptor.
    Wilson HA; Greenblatt D; Taylor CW; Putney JW; Tsien RY; Finkelman FD; Chused TM
    J Immunol; 1987 Mar; 138(6):1712-8. PubMed ID: 2950170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship between growth factor-induced pH changes and intracellular Ca2+.
    Ives HE; Daniel TO
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1950-4. PubMed ID: 3470769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP has the ability to influence multiple events during B cell stimulation.
    Holte H; Torjesen P; Blomhoff HK; Ruud E; Funderud S; Smeland EB
    Eur J Immunol; 1988 Sep; 18(9):1359-66. PubMed ID: 2458941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell stimulation via CD2 molecules is regularly accompanied by an increase in cytoplasmic pH. Different effects of lectins and CD3 antibodies.
    Fischer GF; Holter W; Majdic O; Cragoe EJ; Knapp W
    J Immunol; 1988 Jul; 141(2):404-9. PubMed ID: 3260251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytosolic free calcium in anti-mu-stimulated human B cells is derived partly from extracellular medium and partly from intracellular stores.
    Dugas B; Calenda A; Delfraissy JF; Vazquez A; Bach JF; Galanaud P
    Eur J Immunol; 1987 Sep; 17(9):1323-8. PubMed ID: 2820750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
    J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
    Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
    J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation.
    Valentine MA; Clark EA; Shu GL; Norris NA; Ledbetter JA
    J Immunol; 1988 Jun; 140(12):4071-8. PubMed ID: 3259604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T; Leiserson WM; Asofsky R
    J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
    Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
    J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-dependent intracellular acidification dominates the pH response to mitogen in human T cells.
    Gelfand EW; Cheung RK; Grinstein S
    J Immunol; 1988 Jan; 140(1):246-52. PubMed ID: 3257228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of interleukin 2- and interleukin 4-mediated human B cell proliferation by ionomycin: a possible regulatory role for apoptosis.
    Vazquez A; Auffredou MT; Chaouchi N; Taieb J; Sharma S; Galanaud P; Leca G
    Eur J Immunol; 1991 Oct; 21(10):2311-6. PubMed ID: 1915547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.
    Clark EA; Shu GL; Lüscher B; Draves KE; Banchereau J; Ledbetter JA; Valentine MA
    J Immunol; 1989 Dec; 143(12):3873-80. PubMed ID: 2480376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A; Kehrl JH; Butler JL; Fauci AS
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin.
    Gouy H; Cefai D; Christensen SB; Debré P; Bismuth G
    Eur J Immunol; 1990 Oct; 20(10):2269-75. PubMed ID: 1700752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
    Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
    J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.